Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
The DOI matches its Crossref record.
Abstract
Micro- and macrovascular complications are major causes of disability and death in patients with diabetes mellitus. Functional impairment of endothelial activity precedes the development of morphological alterations during the progression of diabetes. This endothelial dysfunction results from reduced bioavailability of the vasodilator nitric oxide (NO), mainly due to accelerated NO degradation by reactive oxygen species (ROS). Although hyperglycemia, insulin resistance, hyperinsulinemia and dyslipidemia independently contribute to endothelial dysfunction via several distinct mechanisms, increased oxidative stress seems to be the first alteration triggering several others. Mechanisms proposed to explain glucose- and lipid-induced vascular alterations in diabetes include accelerated formation of advanced glycation end-products (AGEs), protein kinase C activation, inflammatory signaling and oxidative stress. Insulin resistance with impaired PI 3-kinase effects decreases insulin mediated production of NO and reduces vasodilation, capillary recruitment and antioxidant properties of endothelium. Compensatory hyperinsulinemia enhances activation of intact MAP-kinase pathways and contributes to pro-atherogenic events by increasing secretion of endothelin-1 (ET-1), stimulating expression of adhesion molecules such as VCAM-1 and E-selectin, and inducing production of ROS. Conventional therapies to reduce hyperglycemia, dyslipidemia and insulin resistance may effectively improve endothelial function and delay the onset of vascular complications. Novel therapeutic approaches designed to inhibit AGEs formation, reduce PKC activation, decrease inflammatory signals and restore the ox/redox balance of endothelium may be predicted to ameliorate vascular function in diabetic state. This review summarizes the current knowledge on the most important mechanisms involved in endothelial dysfunction during diabetes. In addition, novel therapeutic strategies that may result from recently identified targets are also described.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [29]
Citations
Cites
Still being checked.
Cited by
Incalza, M. A., D'Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,356
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
González, P., Lozano, P., Ros, G., & Solano, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119352 · Cited by 777
Kaur, R., Kaur, M., & Singh, J. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0763-3 · Cited by 736
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H. (2022) · Circulation · doi:10.1161/cir.0000000000001040 · Cited by 660
Update of pathophysiology and management of diabetic kidney disease
Lin, Y.-C., Chang, Y.-H., Yang, S.-Y., Wu, K.-D., & Chu, T.-S. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.02.007 · Cited by 562
Endothelial dysfunction : the early predictor of atherosclerosis
Mudau, M., Genis, A., Lochner, A., & Strijdom, H. (2012) · Cardiovascular Journal of Africa · doi:10.5830/cvja-2011-068 · Cited by 521
Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus
Shan, K., Liu, C., Liu, B.-H., Chen, X., Dong, R., Liu, X., Zhang, Y.-Y., Liu, B., Zhang, S.-J., Wang, J.-J., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.029004 · Cited by 504
Leyane, T. S., Jere, S. W., & Houreld, N. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137273 · Cited by 469
The Role of Bilirubin in Diabetes, Metabolic Syndrome, and Cardiovascular Diseases
Vítek, L. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00055 · Cited by 311
Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Hu, R., Wang, M.-Q., Ni, S.-H., Wang, M., Liu, L.-Y., You, H.-Y., Wu, X.-H., Wang, Y.-J., Lu, L., & Wei, L.-B. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172797 · Cited by 196
Endothelial PGC-1α Mediates Vascular Dysfunction in Diabetes
Sawada, N., Jiang, A., Takizawa, F., Safdar, A., Manika, A., Tesmenitsky, Y., Kang, K.-T., Bischoff, J., Kalwa, H., Sartoretto, J. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.014 · Cited by 163
Reactive species and diabetes: counteracting oxidative stress to improve health
Pérez-Matute, P., Zulet, M. A., & Martínez, J. A. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.005 · Cited by 162
Vascular actions of insulin with implications for endothelial dysfunction
Potenza, M. A., Addabbo, F., & Montagnani, M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2009 · Cited by 161
Self-citationNitric oxide – the endothelium-derived relaxing factor and its role in endothelial functions
Bauer, V., & Sotnikova, R. (2010) · General Physiology and Biophysics · doi:10.4149/gpb_2010_04_319 · Cited by 151
Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients
Mrugacz, M., Bryl, A., & Zorena, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030458 · Cited by 174
The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: An update
Zhang, H., Dellsperger, K. C., & Zhang, C. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-011-0237-1 · Cited by 144
“Microvascular consequences include retinopathy and nephropathy, which are regarded as major causes of blindness and end-stage renal failure [51, 60].”
BackgroundCaturano, A., Rocco, M. P., Tagliaferri, G., Piacevole, A., Nilo, D., Lorenzo, G. D., Iadicicco, I., Donnarumma, M., Galiero, R., Acierno, C., et al. (2025) · Antioxidants · doi:10.3390/antiox14010072 · Cited by 209
Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
Ding, P.-F., Zhang, H., Wang, J., Gao, Y., Mao, J.-N., Hang, C., & Li, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1092431 · Cited by 161
The vascular endothelium: A regulator of arterial tone and interface for the immune system
Khaddaj‐Mallat, R., John, C. M., Kendrick, D. J., & Braun, A. P. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1394267 · Cited by 148
Abdelsalam, S. S., Korashy, H. M., Zeidan, A., & Agouni, A. (2019) · Biomolecules · doi:10.3390/biom9070286 · Cited by 147
Endothelial Function and Dysfunction: Impact of Metformin
Nafisa, A., Gray, S. G., Cao, Y., Wang, T., Xu, S., Wattoo, F. H., Barras, M., Cohen, N., Kamato, D., & Little, P. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.07.007 · Cited by 128
Role of Caveolin-1 in Diabetes and Its Complications
Haddad, D., Madhoun, A. S. A., Nizam, R., & Al‐Mulla, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9761539 · Cited by 146
Dhar, A., Dhar, I., Desai, K. M., & Wu, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01017.x · Cited by 125
Blázquez‐Medela, A. M., García‐Ortiz, L., Gómez-Marcos, M. Á., Recio-Rodriguez, J. I., Sánchez-Rodríguez, A., López-Novoa, J. M., & Martínez‐Salgado, C. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-86 · Cited by 133
Maamoun, H., Abdelsalam, S. S., Zeidan, A., Korashy, H. M., & Agouni, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071658 · Cited by 129
Reversibility of endothelial dysfunction in diabetes: role of polyphenols
Suganya, N., Bhakkiyalakshmi, E., Sarada, D. V. L., & Ramkumar, K. M. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516001884 · Cited by 113
Chen, Y., Wang, L., Pitzer, A. L., Li, X., Li, P.-L., & Zhang, Y. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1481-5 · Cited by 108
“Vascular complications are major causes of disability and death in patients with diabetes mellitus [17].”
BackgroundLiu, G., Sun, X., Bian, J., Wu, R., Guan, X., Ouyang, B., Huang, Y., Xiao, H., Luo, D., Atala, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072790 · Cited by 104
Novel Pharmacological Approaches to the Treatment of Type 2 Diabetes
Verspohl, E. J. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003319 · Cited by 112
Karasu, Ç. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010240 · Cited by 107
Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy
Sun, H., Wu, Z., Cao, L., Zhu, M., Liu, T.-T., Guo, L., Lin, Y., Nie, X.-W., & Bian, J. (2019) · Molecules · doi:10.3390/molecules24152857 · Cited by 107
Guo, R., Liu, B., Wang, K., Zhou, S., Li, W., & Xu, Y. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113520332 · Cited by 102
Babu, P. V. A., Si, H., Fu, Z., Wei, Z., & Liu, D. (2012) · Journal of Nutrition · doi:10.3945/jn.111.152322 · Cited by 91
Gou, L., Zhao, L., Song, W., Wang, L., Liu, J., Zhang, H., Huang, Y., Lau, C. W., Yao, X., Tian, X. Y., et al. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7005 · Cited by 92
CircRNA Is a Rising Star in Researches of Ocular Diseases
Zhang, C., Hu, J., & Yu, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00850 · Cited by 96
Protective effects of genistein in homocysteine-induced endothelial cell inflammatory injury
Han, S., Wu, H. B. K., Li, W., & Gao, P. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2335-0 · Cited by 84
Cardioprotective Effects of Metformin
Driver, C., Bamitale, K. O., Kazi, A., Olla, M., Nyane, N. A., & Owira, P. M. O. (2018) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000599 · Cited by 87
Popov, D. (2010) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2010.09.002 · Cited by 94
Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice
Cho, Y.-E., Basu, A., Dai, A., Heldak, M., & Makino, A. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00234.2013 · Cited by 76
Oxidative Stress and Microvessel Barrier Dysfunction
He, P., Talukder, M. A. H., & Gao, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00472 · Cited by 83
L-Arginine in diabetes: clinical and preclinical evidence
Forzano, I., Avvisato, R., Varzideh, F., Jankauskas, S. S., Cioppa, A., Mone, P., Salemme, L., Kansakar, U., Tesorio, T., Trimarco, V., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01827-2 · Cited by 93
Angiotensin (1-7) and Alamandine: Similarities and differences
Qaradakhi, T., Apostolopoulos, V., & Zulli, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.025 · Cited by 73
Navasiolava, N. M., Yuan, M., Murphy, R. P., Robin, A., Coupé, M., Wang, L., Alameddine, A., Gauquelin‐Koch, G., Gharib, C., Li, Y., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00952 · Cited by 78
Gao, F., Lucke-Wold, B. P., Li, X., Logsdon, A. F., Xu, L., Xu, S., LaPenna, K. B., Wang, H., Talukder, M. A. H., Siedlecki, C. A., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2017.01124 · Cited by 75
Serizawa, K., Yogo, K., Aizawa, K., Tashiro, Y., & Ishizuka, N. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-105 · Cited by 68
Li, H., Peng, W., Jian, W., Li, Y., Li, Q., Li, W., & Xu, Y. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-65 · Cited by 64
Potential Role for Osteocalcin in the Development of Atherosclerosis and Blood Vessel Disease
Tacey, A., Qaradakhi, T., Brennan‐Speranza, T. C., Hayes, A., Zulli, A., & Levinger, I. (2018) · Nutrients · doi:10.3390/nu10101426 · Cited by 65
Bazyar, H., Moradi, L., Zaman, F., & Javid, A. Z. (2022) · Phytotherapy Research · doi:10.1002/ptr.7611 · Cited by 70
Gómez-Marcos, M. Á., Blázquez‐Medela, A. M., Gamella-Pozuelo, L., Recio-Rodriguez, J. I., García‐Ortiz, L., & Martínez‐Salgado, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9124676 · Cited by 67
Nie, Q., Zhu, L., Zhang, L., Leng, B., & Wang, H. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116662 · Cited by 65
Soluble endoglin, hypercholesterolemia and endothelial dysfunction
Rathouska, J., Ježková, K., Němečková, I., & Nachtigal, P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.003 · Cited by 67
Treating Coronary Disease and the Impact of Endothelial Dysfunction
Matsuzawa, Y., Guddeti, R. R., Kwon, T.-G., Lerman, L. O., & Lerman, A. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2014.10.004 · Cited by 57
Vascular mechanisms of cyanidin-3-glucoside response in streptozotocin-diabetic rats
Nasri, S., Roghani, M., Baluchnejadmojarad, T., Rabani, T., & Balvardi, M. (2011) · Pathophysiology · doi:10.1016/j.pathophys.2011.03.001 · Cited by 61
Tomić, M., Ljubić, S., Kaštelan, S., Antunica, A. G., Jazbec, A., & Poljičanin, T. (2013) · Mediators of Inflammation · doi:10.1155/2013/818671 · Cited by 71
Nanomedicines for endothelial disorders
Chung, B. L., Toth, M. J., Kamaly, N., Sei, Y. J., Becraft, J. R., Mulder, W. J. M., Fayad, Z. A., Farokhzad, O. C., Kim, Y., & Langer, R. (2015) · Nano Today · doi:10.1016/j.nantod.2015.11.009 · Cited by 60
Wu, Y., Li, Y., Liao, X., Wang, Z., Li, R., Zou, S., Jiang, T., Zheng, B., Duan, P., & Xiao, J. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.21172 · Cited by 61
Davis, G. E., Norden, P. R., & Bowers, S. (2015) · Connective Tissue Research · doi:10.3109/03008207.2015.1066781 · Cited by 58
Tang, S.-G., Liu, X., Ye, J., Hu, T., Yang, Y., Han, T., & Tan, W. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0681 · Cited by 56
Glaser, N. S., Ngo, C. T., Anderson, S., Yuen, N., Trifu, A., & O’Donnell, M. E. (2012) · Diabetes · doi:10.2337/db11-1286 · Cited by 58
Novel mechanisms of endothelial dysfunction in diabetes
Yang, G., Lucas, R., Caldwell, R. B., Yao, L., Romero, M. J., & Caldwell, R. W. (2010) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.64432 · Cited by 64
Das, A. K., Gopalakrishnan, B., Voss, O. H., Doseff, A. I., & Villamena, F. A. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.021 · Cited by 54
Wang, G., Wu, S., Xu, W., Jin, H. W., Zhu, Z., Li, Z., Tian, Y., Zhang, J., Rao, J.-J., & Wu, S. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.83 · Cited by 52
Dhar, I., Dhar, A., Wu, L., & Desai, K. M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192112 · Cited by 54
Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats
Mizukami, H., Ogasawara, S., Yamagishi, S., Takahashi, K., & Yagihashi, S. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02430.x · Cited by 51
Long-Term Results of Gastric Bypass Surgery in Morbidly Obese Type 1 Diabetes Patients
Czupryniak, L., Wiszniewski, M., Szymański, D., Pawłowski, M., Loba, J., & Strzelczyk, J. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0074-6 · Cited by 50
Babu, P. V. A., Si, H., & Liu, D. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200040 · Cited by 48
Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes
Blázquez‐Medela, A. M., García‐Ortiz, L., Gómez-Marcos, M. Á., Recio-Rodriguez, J. I., Sánchez‐Rodríguez, A., López-Novoa, J. M., & Martínez‐Salgado, C. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02619.x · Cited by 51
Lupin and soya reduce glycaemia acutely in type 2 diabetes
Dove, E. R., Mori, T. A., Chew, G. T., Barden, A. E., Woodman, R. J., Puddey, I. B., Sipsas, S., & Hodgson, J. M. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511001334 · Cited by 53
Association between circulating cell adhesion molecules and risk of type 2 diabetes: A meta-analysis
Qiu, S., Cai, X., Liu, J., Yang, B., Zügel, M., Steinacker, J. M., Sun, Z., & Schümann, U. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.06.908 · Cited by 51
Potenza, M. A., Gagliardi, S., Benedictis, L. D., Zigrino, A., Tiravanti, E., Colantuono, G., Federici, A., Lorusso, L., Benagiano, V., Quon, M. J., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00291.2009 · Cited by 47
Self-citationAge-dependent alteration of antioxidant defense system in hypertensive and type-2 diabetes patients
Okoduwa, S. I., Umar, I. A., Ibrahim, S., Bello, F., & Habila, N. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0164-z · Cited by 45
Kajihara, N., Kukidome, D., Sada, K., Motoshima, H., Furukawa, N., Matsumura, T., Nishikawa, T., & Araki, E. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12678 · Cited by 47
Petrofsky, J. S. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500319 · Cited by 44
Qian, Q., Qian, S., Fan, P., Huo, D., & Wang, S. (2011) · Phytotherapy Research · doi:10.1002/ptr.3513 · Cited by 44
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects
Pereira, T. D. M. C., Pimenta, F. S., Porto, M. L., Baldo, M. P., Campagnaro, B. P., Gava, A. L., Meyrelles, S. S., & Vasquez, E. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081273 · Cited by 44
Curcumin derivatives for Type 2 Diabetes management and prevention of complications
Oliveira, S., Monteiro‐Alfredo, T., Silva, S., & Matafome, P. N. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01240-3 · Cited by 50
C-Peptide as a Therapy for Type 1 Diabetes Mellitus
Washburn, R. L., Mueller, K., Kaur, G., Moreno, T., Moustaïd‐Moussa, N., Ramalingam, L., & Dufour, J. M. (2021) · Biomedicines · doi:10.3390/biomedicines9030270 · Cited by 55
Dymkowska, D., Drabarek, B., Podszywalow‐Bartnicka, P., Szczepanowska, J., & Zabłocki, K. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.11.008 · Cited by 45
Coco, C., Sgarra, L., Potenza, M. A., Nacci, C., Pasculli, B., Barbano, R., Parrella, P., & Montagnani, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122949 · Cited by 47
Self-citationPang, A., Hu, Y., Zhou, P., Long, G., Tian, X., Men, L., Shen, Y., Liu, Y., & Cui, Y. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0298-9 · Cited by 42
Ritchie, S. A., Kohlhaas, C. F., Boyd, A. R., Yalla, K. C., Walsh, K. X., Connell, J., & Salt, I. P. (2009) · Biochemical Journal · doi:10.1042/bj20091580 · Cited by 45
Erectile dysfunction in heart failure patients: a critical reappraisal
Alberti, L., Torlasco, C., Lauretta, L., Loffi, M., Maranta, F., Salonia, A., Margonato, A., Montorsi, F., & Fragasso, G. (2013) · Andrology · doi:10.1111/j.2047-2927.2012.00048.x · Cited by 40
Suzuki, K., Watanabe, K., Futami‐Suda, S., Yano, H., Motoyama, M., Matsumura, N., Igari, Y., Suzuki, T., Nakano, H., & Oba, K. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-98 · Cited by 40
Lipids, lipid-lowering therapy and diabetes complications
Valensi, P. E., & Picard, S. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.10.001 · Cited by 38
Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3
Darrow, A. L., Shohet, R. V., & Maresh, J. G. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00035.2011 · Cited by 38
Abebe, W., & Mozaffari, M. S. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0012-7 · Cited by 38
Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus
Yun, J., Ko, S., Kim, J., Moon, K.-W., Park, Y., Yoo, K., & Ahn, Y. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.4.262 · Cited by 38
Kuryliszyn-Moskal, A., Zarzycki, W., Dubicki, A., Moskal, D., Kosztyła‐Hojna, B., & Hryniewicz, A. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.11.007 · Cited by 35
Management of Invasive Infections in Diabetes Mellitus: A Comprehensive Review
Khanam, A., Hithamani, G., Jayapala, N., Pradeep, S. R., Barman, S., & Srinivasan, K. (2023) · Biologics · doi:10.3390/biologics3010004 · Cited by 51
Ramprasath, T., & Selvam, G. S. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990154 · Cited by 35
Feng, J., Liu, L., Yao, F., Zhou, D., He, Y., & Wang, J. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1878877 · Cited by 37
Sanz, M.-N., Sànchez‐Martìn, C., Détaille, D., Vial, G., Rigoulet, M., El-Mir, M.-Y., & Villanueva, G. R. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335804 · Cited by 34
Pidala, J., Kim, J., Kharfan‐Dabaja, M. A., Nishihori, T., Field, T. L., Perkins, J., Perez, L. E., Fernandez, H. F., & Anasetti, C. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.07.005 · Cited by 34
Son, W.-R., Nam, M., Hong, C., Kim, Y., & Lee, K. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1570-1 · Cited by 36
Tanaka, A., Shimabukuro, M., Okada, Y., Taguchi, I., Yamaoka‐Tojo, M., Tomiyama, H., Teragawa, H., Sugiyama, S., Yoshida, H., Sato, Y., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0532-8 · Cited by 37
Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss
Sharma, Y., Saxena, S., Mishra, A., Saxena, A., & Natu, S. M. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1406-2 · Cited by 38
Lim, K. H., Han, J.-H., Lee, J. Y., Park, Y. S., Cho, Y. S., Kang, K., Yuk, W.-J., Hwang, K. Y., Seong, S., Kim, B., et al. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.08.036 · Cited by 31
Even, S., Dulak-Lis, M. G., Touyz, R. M., & Cat, A. N. D. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0013 · Cited by 34
Metadata
- Authors
- Potenza, M., Gagliardi, S., Nacci, C., Carratu, M., & Montagnani, M.
- Affiliations
- University of Bari Aldo Moro (IT)
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-01-01
- Volume
- 16
- Issue
- 1
- Pages
- 94-112
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2116006961
- Cited by
- 280
- References
- 0
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 7 · 2023: 12 · 2022: 13 · 2021: 9 · 2020: 17 · 2019: 15 · 2018: 13 · 2017: 16 · 2016: 14 · 2015: 16 · 2014: 18 · 2013: 22 · 2012: 25
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- endothelial dysfunction, diabetes mellitus, nitric oxide bioavailability, reactive oxygen species, oxidative stress, advanced glycation end products, protein kinase C, insulin resistance, hyperinsulinemia, dyslipidemia, endothelin-1, adhesion molecules, vascular inflammation, PI3-kinase, MAPK signaling, diabetic vascular complications, therapeutic target
- MeSH terms
- Animals, Hypolipidemic Agents, Diabetic Angiopathies, Endothelium, Vascular, Humans, Hypoglycemic Agents, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.